post hoc of the PEXIVAS study 704 participants w/ severe ANCA vasculitis: 92% achieved remission & 23% had relapses (rate 10.3/100PYs)-- Neither plasma exchange nor glucocorticoid tapering regimen impacted relapse risk. https://t.co/LKaqptWbxZ https://t.co/nOvE6BqYOl
Links:
The risk of relapse of ANCA‐associated vasculitis in a randomized controlled tr…
https://buff.ly/3Vq4yTL
Mar-24-2024
